搜尋





搜尋





市場行情
/
股票
/
pcvx
/

Vaxcyte Inc

PCVX

添加自選

54.080USD

-1.880-3.36%

收盤 07-31 16:00（美東）報價延遲15分鐘

7.80B總市值

虧損本益比TTM

Vaxcyte Inc

54.080

-1.880-3.36%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

PCVX 利潤表

您可以在這裡找到Vaxcyte Inc的年度或季度收入報告，以深入了解Vaxcyte Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

營業費用

91.30%345.85M

69.13%274.28M

73.58%242.38M

48.26%226.22M

58.11%180.79M

33.29%162.17M

25.36%139.63M

80.19%152.59M

62.11%114.35M

94.20%121.67M

90.66%111.39M

79.43%84.68M

80.58%70.54M

116.51%62.65M

119.20%58.42M

102.11%47.20M

68.78%39.06M

53.70%28.94M

29.88%26.65M

15.67%23.35M

-15.12%23.14M

--18.83M

--20.52M

65.04%20.19M

95.55%27.27M

--12.23M

--13.94M

研發費用

111.15%312.78M

81.16%242.06M

79.53%209.93M

47.66%194.18M

56.61%148.13M

28.29%133.61M

20.03%116.94M

80.91%131.51M

62.86%94.59M

101.74%104.15M

104.33%97.42M

88.96%72.69M

83.34%58.08M

123.74%51.63M

133.40%47.68M

117.94%38.47M

83.56%31.68M

57.38%23.07M

24.49%20.43M

-2.90%17.65M

-29.02%17.26M

--14.66M

--16.41M

82.36%18.18M

92.55%24.32M

--9.97M

--12.63M

折舊攤銷及損耗

-0.30%2.95M

161.77%7.50M

71.36%3.06M

112.94%2.88M

195.90%2.96M

222.52%2.86M

121.84%1.79M

80.27%1.35M

40.31%999.00K

26.50%888.00K

17.84%806.00K

23.15%750.00K

22.34%712.00K

52.94%702.00K

34.12%684.00K

25.83%609.00K

67.72%582.00K

38.25%459.00K

52.69%510.00K

36.34%484.00K

-9.64%347.00K

--332.00K

--334.00K

17.55%355.00K

30.61%384.00K

--302.00K

--294.00K

其他營業費用

----

82.20%-292.00K

84.01%-394.00K

80.73%-126.00K

99.35%-6.00K

-944.59%-1.64M

-257.10%-2.46M

-308.75%-654.00K

-1.87%-925.00K

47.49%-157.00K

-82.54%-690.00K

---160.00K

-45.05%-908.00K

62.01%-299.00K

63.51%-378.00K

100.00%0.00

---626.00K

---787.00K

---1.04M

---329.00K

----

--0.00

營業利潤

-91.30%-345.85M

-69.13%-274.28M

-73.58%-242.38M

-48.26%-226.22M

-58.11%-180.79M

-33.29%-162.17M

-25.36%-139.63M

-80.19%-152.59M

-62.11%-114.35M

-94.20%-121.67M

-90.66%-111.39M

-79.43%-84.68M

-80.58%-70.54M

-116.51%-62.65M

-119.20%-58.42M

-102.11%-47.20M

-68.78%-39.06M

-53.70%-28.94M

-29.88%-26.65M

-15.67%-23.35M

15.12%-23.14M

---18.83M

---20.52M

-65.04%-20.19M

-95.55%-27.27M

---12.23M

---13.94M

淨非營業利息收入（費用）

利息收入

-19.20%26.61M

-27.45%26.45M

4.28%29.26M

30.49%31.07M

52.01%32.94M

107.53%36.46M

51.70%28.06M

44.75%23.81M

108.47%21.67M

164.86%17.57M

1454.20%18.50M

4023.06%16.45M

7655.97%10.39M

6600.00%6.63M

1222.22%1.19M

329.03%399.00K

119.67%134.00K

209.38%99.00K

172.73%90.00K

111.36%93.00K

-54.81%61.00K

--32.00K

--33.00K

-75.69%44.00K

-42.80%135.00K

--181.00K

--236.00K

利息費用

----

--0.00

-100.00%0.00

----

--0.00

-71.43%2.00K

----

--0.00

--7.00K

-100.00%0.00

--0.00

-100.00%0.00

-46.15%7.00K

--11.00K

--13.00K

出售證券收益

----

3622.91%8.45M

166.36%71.00K

-638.17%-2.34M

-268.38%-1.70M

133.04%227.00K

93.83%-107.00K

-437.29%-317.00K

265.58%1.01M

-1196.23%-687.00K

-319.61%-1.73M

-103.17%-59.00K

116.81%276.00K

90.00%-53.00K

-134.66%-413.00K

62166.67%1.86M

---1.64M

---530.00K

-232.08%-176.00K

98.30%-3.00K

---53.00K

---176.00K

特殊收入（費用）

----

--0.00

----

100.00%0.00

----

-225.53%-75.00M

----

---23.04M

----

100.00%0.00

----

---300.00K

----

其他非經營性收入（費用）

-119.36%-1.38M

111.65%1.32M

--291.00K

--28.57M

--7.14M

---11.37M

----

--0.00

----

--0.00

-100.00%0.00

--1.45M

--226.00K

稅前利潤

-127.85%-320.62M

-79.83%-246.51M

-106.38%-212.83M

-29.42%-166.57M

-48.09%-140.72M

24.18%-137.08M

-11.29%-103.12M

-88.33%-128.70M

-57.16%-95.02M

-131.65%-180.80M

-59.99%-92.66M

-40.81%-68.34M

-55.09%-60.46M

-173.26%-78.05M

-117.61%-57.92M

-104.96%-48.53M

-83.72%-38.99M

-37.74%-28.56M

-26.63%-26.61M

-16.53%-23.68M

21.82%-21.22M

---20.74M

---21.02M

-90.53%-20.32M

-98.54%-27.14M

---10.66M

---13.67M

所得稅

--0.00

----

除稅後利潤

-127.85%-320.62M

-79.83%-246.51M

-106.38%-212.83M

-29.42%-166.57M

-48.09%-140.72M

24.18%-137.08M

-11.29%-103.12M

-88.33%-128.70M

-57.16%-95.02M

-131.65%-180.80M

-59.99%-92.66M

-40.81%-68.34M

-55.09%-60.46M

-173.26%-78.05M

-117.61%-57.92M

-104.96%-48.53M

-83.72%-38.99M

-37.74%-28.56M

-26.63%-26.61M

-16.53%-23.68M

21.82%-21.22M

---20.74M

---21.02M

-90.53%-20.32M

-98.54%-27.14M

---10.66M

---13.67M

持續經營利潤

-127.85%-320.62M

-79.83%-246.51M

-106.38%-212.83M

-29.42%-166.57M

-48.09%-140.72M

24.18%-137.08M

-11.29%-103.12M

-88.33%-128.70M

-57.16%-95.02M

-131.65%-180.80M

-59.99%-92.66M

-40.81%-68.34M

-55.09%-60.46M

-173.26%-78.05M

-117.61%-57.92M

-104.96%-48.53M

-83.72%-38.99M

-37.74%-28.56M

-26.63%-26.61M

-16.53%-23.68M

21.82%-21.22M

---20.74M

---21.02M

-90.53%-20.32M

-98.54%-27.14M

---10.66M

---13.67M

歸属于母公司的淨利潤

-127.85%-320.62M

-79.83%-246.51M

-106.38%-212.83M

-29.42%-166.57M

-48.09%-140.72M

24.18%-137.08M

-11.29%-103.12M

-88.33%-128.70M

-57.16%-95.02M

-131.65%-180.80M

-59.99%-92.66M

-40.81%-68.34M

-55.09%-60.46M

-173.26%-78.05M

-117.61%-57.92M

-104.96%-48.53M

-83.72%-38.99M

-37.74%-28.56M

-26.63%-26.61M

-16.53%-23.68M

21.82%-21.22M

---20.74M

---21.02M

-90.53%-20.32M

-98.54%-27.14M

---10.66M

---13.67M

歸屬普通股東的淨利潤

-127.85%-320.62M

-79.83%-246.51M

-106.38%-212.83M

-29.42%-166.57M

-48.09%-140.72M

24.18%-137.08M

-11.29%-103.12M

-88.33%-128.70M

-57.16%-95.02M

-131.65%-180.80M

-59.99%-92.66M

-40.81%-68.34M

-55.09%-60.46M

-173.26%-78.05M

-117.61%-57.92M

-104.96%-48.53M

-83.72%-38.99M

-37.74%-28.56M

-26.63%-26.61M

-16.53%-23.68M

21.82%-21.22M

---20.74M

---21.02M

-90.53%-20.32M

-98.54%-27.14M

---10.66M

---13.67M

基本每股收益

-121.62%-2.30

-78.20%-1.81

-87.44%-1.56

-11.56%-1.22

-21.90%-1.04

42.50%-1.01

8.53%-0.83

-57.49%-1.10

-21.30%-0.85

-78.52%-1.76

2.45%-0.91

12.66%-0.70

-3.53%-0.70

-82.63%-0.99

-83.20%-0.93

-73.58%-0.80

-63.37%-0.68

-33.34%-0.54

-23.50%-0.51

-15.11%-0.46

26.08%-0.41

---0.41

86.21%-0.40

-98.54%-0.56

---2.90

---0.28

稀釋每股收益

-121.62%-2.30

-78.20%-1.81

-87.44%-1.56

-11.56%-1.22

-21.90%-1.04

42.50%-1.01

8.53%-0.83

-57.49%-1.10

-21.30%-0.85

-78.52%-1.76

2.45%-0.91

12.66%-0.70

-3.53%-0.70

-82.63%-0.99

-83.20%-0.93

-73.58%-0.80

-63.37%-0.68

-33.34%-0.54

-23.50%-0.51

-15.11%-0.46

26.08%-0.41

---0.41

86.21%-0.40

-98.54%-0.56

---2.90

---0.28

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Vaxcyte Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 PCVX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Vaxcyte Inc 全年的淨利潤是多少？



Vaxcyte Inc 2025 財年淨利潤為 -766.63M。

Vaxcyte Inc 上一季度的淨利潤是多少？



Vaxcyte Inc 最近一個季度的淨利潤為 -320.62M。

Vaxcyte Inc 年度營業利潤是多少？



Vaxcyte Inc 2025 財年的營業利潤為 -923.67M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。